The subvariant accounted for 27.6 percent of U.S. COVID-19 cases in the week ending Jan. 7, up from 18.3 percent the week prior, CDC estimates show.
The Northeast has the highest proportion of cases from XBB.1.5 — sitting at more than 70 percent — while states in the Midwest have the lowest at about 5 percent.
Below is a breakdown of the subvariant’s prevalence in each HHS surveillance region as of Jan. 6:
|
HHS surveillance region |
Prevalence of XBB.1.5 |
|
Region 1 Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island and Vermont |
71.6 percent of all COVID-19 cases |
|
Region 2 New Jersey, New York, Puerto Rico and the Virgin Islands |
72.7 |
|
Region 3 Delaware, District of Columbia, Maryland, Pennsylvania, Virginia and West Virginia |
32.1 |
|
Region 4 Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina and Tennessee |
17.3 |
|
Region 5 Illinois, Indiana, Michigan, Minnesota, Ohio and Wisconsin |
7.3 |
|
Region 6 Arkansas, Louisiana, New Mexico, Oklahoma and Texas |
16.6 |
|
Region 7 Iowa, Kansas, Missouri and Nebraska |
5.6 |
|
Region 8 Colorado, Montana, North Dakota, South Dakota, Utah and Wyoming |
6.6 |
|
Region 9 Arizona, California, Hawaii, Nevada, American Samoa, Commonwealth of the Northern Mariana Islands, Federated States of Micronesia, Guam, Marshall Islands and Republic of Palau |
7.6 |
|
Region 10 Alaska, Idaho, Oregon and Washington |
6.7 |
For more information on XBB.1.5’s transmissibility and severity, click here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
